Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 5/20 | 0.46 |
| ▸ | CCR8 | P51685 | 5/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | CCR5 | P51681 | 3/20 | 0.39 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.39 |
| ▸ | COPS5 | Q92905 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5487806 | 0.90 | CCR1 (0.49) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL14363705 | 0.87 | L3MBTL1 (0.47) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL5490667 | 0.86 | CCR1 (0.37) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL14579753 | 0.84 | CCR1 (0.49) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL14363717 | 0.84 | CCR1 (0.42) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL5493934 | 0.84 | CCR1 (0.39) | CCR1CCR8L3MBTL1ALDH1A1CCR5 | |
| SCHEMBL14579757 | 0.84 | CCR1 (0.46) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL14363706 | 0.82 | L3MBTL1 (0.39) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL14579756 | 0.82 | L3MBTL1 (0.47) | CCR1CCR8L3MBTL1NPC1HSP90AA1 | |
| SCHEMBL14579760 | 0.82 | L3MBTL1 (0.47) | CCR1CCR8L3MBTL1NPC1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7989089-B2 | 2-(9-anthryl)imidazo[4,5-f]-[1,10]phenanthroline (2) or 2-(2-pyridyl)imidazo[4,5-f]-[1,10]phenanthroline (4) | LG DISPLAY CO., LTD. (KR) | 2011-08-02 | — | — | US | claimed |
| US-7291404-B2 | Organic light emitting devices | LG.PHILIPS LCD CO., LTD. (KR) | 2007-11-06 | — | — | US | claimed |
| US-20040265628-A1 | Organic luminescent compounds and methods of making and using same | LG DISPLAY CO., LTD. (KP) | 2004-12-30 | — | — | US | claimed |
| US-7989089-B2 | 2-(9-anthryl)imidazo[4,5-f]-[1,10]phenanthroline (2) or 2-(2-pyridyl)imidazo[4,5-f]-[1,10]phenanthroline (4) | LG DISPLAY CO., LTD. (KR) | 2011-08-02 | — | — | US | disclosed |
| US-7989089-B2 | 2-(9-anthryl)imidazo[4,5-f]-[1,10]phenanthroline (2) or 2-(2-pyridyl)imidazo[4,5-f]-[1,10]phenanthroline (4) | LG DISPLAY CO., LTD. (KR) | 2011-08-02 | — | — | US | disclosed |
| US-7989089-B2 | 2-(9-anthryl)imidazo[4,5-f]-[1,10]phenanthroline (2) or 2-(2-pyridyl)imidazo[4,5-f]-[1,10]phenanthroline (4) | LG DISPLAY CO., LTD. (KR) | 2011-08-02 | — | — | US | disclosed |
| US-7291404-B2 | Organic light emitting devices | LG.PHILIPS LCD CO., LTD. (KR) | 2007-11-06 | — | — | US | disclosed |
| US-7291404-B2 | Organic light emitting devices | LG.PHILIPS LCD CO., LTD. (KR) | 2007-11-06 | — | — | US | disclosed |
| US-7291404-B2 | Organic light emitting devices | LG.PHILIPS LCD CO., LTD. (KR) | 2007-11-06 | — | — | US | disclosed |
| US-20040265628-A1 | Organic luminescent compounds and methods of making and using same | LG DISPLAY CO., LTD. (KP) | 2004-12-30 | — | — | US | disclosed |
| US-20040209117-A1 | Organic light emitting devices | XEROX CORPORATION | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040209117-A1 | Organic light emitting devices | OXA1L, OCIAD1, SLCO4C1 | CCR1 2553/4885CCR8 3439/4885L3MBTL1 3964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.